VENUS REMEDIES LTD. SHARE PRICE [LIVE]

BSE: INE411B01019   NSE: VENUSREM   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
215.60
Change:
BSE
215.90
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in VENUS REMEDIES LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

VENUSREM News

Frequently Asked Questions

What is the Share price of VENUS REMEDIES LTD. (VENUSREM)?

VENUS REMEDIES LTD. (VENUSREM) share price as of August 18, 2022, on NSE is Rs 215.60 (NSE) and Rs 215.90 (BSE) on BSE.

Can I buy VENUS REMEDIES LTD. (VENUSREM) shares?

Yes, You can buy VENUS REMEDIES LTD. (VENUSREM) shares by opening a Demat account with Angel One.

How do I buy VENUS REMEDIES LTD. (VENUSREM) from Angel One?

VENUS REMEDIES LTD. (VENUSREM) share can be brought through the following modes:
  1. Direct investment: You can buy VENUS REMEDIES LTD. (VENUSREM) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to VENUS REMEDIES LTD. (VENUSREM) shares.

In which sector do VENUS REMEDIES LTD. (VENUSREM) belong?

VENUS REMEDIES LTD. (VENUSREM) belongs to Pharma.

About VENUSREM

Today's live share price for VENUS REMEDIES LTD. is NSE: ₹ 215.60, BSE: ₹ 215.90 with a current market capitalization of .

Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as 'WHO-GMP' as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc. In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.

Read more